Vemula Harika, Kitase Yukiko, Ayon Navid J, Bonewald Lynda, Gutheil William G
Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.
Department of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.
Anal Biochem. 2017 Jan 1;516:75-85. doi: 10.1016/j.ab.2016.10.017. Epub 2016 Oct 19.
Isomeric molecules present a challenge for analytical resolution and quantification, even with MS-based detection. The eight aminobutyric acid (ABA) isomers are of interest for their various biological activities, particularly γ-aminobutyric acid (GABA) and the d- and l-isomers of β-aminoisobutyric acid (β-AIBA; BAIBA). This study aimed to investigate LC-MS/MS-based resolution of these ABA isomers as their Marfey's (Mar) reagent derivatives. HPLC was able to separate three Mar-ABA isomers l-β-ABA (l-BABA), and l- and d-α-ABA (AABA) completely, with three isomers (GABA, and d/l-BAIBA) in one chromatographic cluster, and two isomers (α-AIBA (AAIBA) and d-BABA) in a second cluster. Partially separated cluster components were deconvoluted using Gaussian peak fitting except for GABA and d-BAIBA. MS/MS detection of Marfey's derivatized ABA isomers provided six MS/MS fragments, with substantially different intensity profiles between structural isomers. This allowed linear deconvolution of ABA isomer peaks. Combining HPLC separation with linear and Gaussian deconvolution allowed resolution of all eight ABA isomers. Application to human serum found a substantial level of l-AABA (13 μM), an intermediate level of l-BAIBA (0.8 μM), and low but detectable levels (<0.2 μM) of GABA, l-BABA, AAIBA, d-BAIBA, and d-AABA. This approach should be useful for LC-MS/MS deconvolution of other challenging groups of isomeric molecules.
即使采用基于质谱的检测方法,同分异构体分子的分析分离和定量仍具有挑战性。八种氨基丁酸(ABA)异构体因其各种生物活性而备受关注,特别是γ-氨基丁酸(GABA)以及β-氨基异丁酸(β-AIBA;BAIBA)的d-和l-异构体。本研究旨在研究基于液相色谱-串联质谱法(LC-MS/MS)对这些ABA异构体作为其马费氏(Mar)试剂衍生物的分离情况。高效液相色谱(HPLC)能够完全分离三种Mar-ABA异构体,即l-β-ABA(l-BABA)、l-和d-α-ABA(AABA),三种异构体(GABA以及d/l-BAIBA)在一个色谱簇中,另外两种异构体(α-AIBA(AAIBA)和d-BABA)在第二个簇中。除了GABA和d-BAIBA外,对部分分离的簇成分使用高斯峰拟合进行去卷积处理。对马费氏衍生化的ABA异构体进行串联质谱检测得到了六个串联质谱碎片,结构异构体之间的强度分布存在显著差异。这使得能够对ABA异构体峰进行线性去卷积处理。将HPLC分离与线性和高斯去卷积相结合,实现了所有八种ABA异构体的分离。应用于人体血清发现,l-AABA含量较高(13 μM),l-BAIBA含量中等(0.8 μM),而GABA、l-BABA、AAIBA、d-BAIBA和d-AABA含量较低但可检测到(<0.2 μM)。这种方法对于其他具有挑战性的同分异构体分子组的LC-MS/MS去卷积处理应该是有用的。